ViaDerma (OTCMKTS:VDRM) Intends to Carry out Additional Internal Quality Control Testing for its New Vitastem Products

June 23, 2022

A publicly-traded specialty pharmaceutical company, ViaDerma, Inc. (OTCMKTS:VDRM) is actively involved in bringing new products to market while licensing its cutting-edge technology to key players in the pharmaceutical industry in a wide variety of therapeutic areas. Trading Data      On Wednesday, VDRM stock moved down 3.68% to $0.0066 with more than 2.65 million shares, compared to its average volume of 1.87 million shares. The stock moved within a range of $0.0060…